title: Galantamine improves gait performance in patients with Alzheimer's disease.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Assal
authors.forename: Gilles
authors.initials: G
authors.lastname: Allali
authors.forename: Reto W
authors.initials: RW
authors.lastname: Kressig
authors.forename: François R
authors.initials: FR
authors.lastname: Herrmann
authors.forename: Olivier
authors.initials: O
authors.lastname: Beauchet
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D001288:Attention / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005684:Gait / Q000187:drug effects*; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D009460:Neurologic Examination / Q000187:drug effects; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*
chemical_list: D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D005702:Galantamine